Western pharmaceutical groups are turning to Chinese biotechs to offset an impending patent cliff, Chinese power-equipment manufacturers are deepening their role in US AI infrastructure despite tariffs, Cambodia is recalibrating to reduce over-dependence on China amid US trade pressure, and India is facing higher costs as Beijing tightens technology-transfer controls.

Major AI firms are considering public listings as private capital growth slows, robotaxi services are reaching commercial scale in the US and China, the Belt and Road Initiative is shifting toward resource investment amid changing capital flows, and the US is exploring rare earth partnerships with Brazil to diversify supply chains.

Rising AI power demand is pushing US data centres toward costly on-site fossil fuel generation, Chinese open-source AI models are gaining global share, Mexico has imposed tariffs on Chinese imports to protect domestic industry, and the EU is creating a compact EV class to help local carmakers compete.